title: [Chronological change in the national health insurance reimbursement based on the DPC package payment system regarding 131I internal therapy].
abstract: The national health reimbursement in 131I internal therapy for thyroid cancer and Graves' disease has increased by introducing the DPC package payment system. The thyroid cancer administration fee for shield room should be increased because of the strict regulation for 131I internal therapy, expensive equipments, confinement of radiopharmaceutical supply, and low efficiency in admission to shield rooms. In addition, the Graves' disease administration fee for shield room should be introduced since the inpatients undergo the same administration and care as the thyroid cancer inpatients.
authors: Department of Radiology, National Defense Medical College.
authors: Masaaki
authors: M
authors: Kunishima
authors: Chiharu
authors: C
authors: Sakaguchi
authors: Tamotsu
authors: T
authors: Kita
authors: Sadahiro
authors: S
authors: Watanabe
authors: Fuzuki
authors: F
authors: Yano
authors: Shigeyoshi
authors: S
authors: Soga
authors: Hiroshi
authors: H
authors: Shinmoto
authors: Shigeru
authors: S
authors: Kosuda
mesh_terms: D018588:Fee-for-Service Plans / Q000191:economics*; D006111:Graves Disease / Q000191:economics* / Q000532:radiotherapy*; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics* / Q000639:trends*; D007457:Iodine Radioisotopes / Q000191:economics* / Q000627:therapeutic use*; D007564:Japan; D009313:National Health Programs / Q000639:trends*; D019275:Radiopharmaceuticals / Q000191:economics* / Q000627:therapeutic use*; D012051:Reimbursement Mechanisms / Q000191:economics*; D013964:Thyroid Neoplasms / Q000191:economics* / Q000532:radiotherapy*
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals